Dosidal · Switzerland

Gliclazid-Mepha 60 retard, Depotabs

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:65571 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 65571
atc: A10BB09
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2015-02-26
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A10BB09
authorisation_number: 65571
form: RETT
holder: Mepha Pharma AG
holder_partner_nr: 1006155
it_number: 07.06.2.
name: Gliclazid-Mepha 60 retard, Depotabs
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
VZYE5qHVGrkW_IlmBeSUBZ2QiwpoqsIKB33F90gBSJzGu6mepIug3HWDw-_dD5_53XEpRh7SILRHpMz0gIMVQA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:65571 · Related records in other markets · Dosidal